BioCentury
ARTICLE | Company News

ActivX, Sosei Co. Ltd. deal

January 13, 2003 8:00 AM UTC

ActivX will use its Xhibit and Xsite proteomics technologies to profile a collection of compounds from Sosei that have known clinical safety and toxicity profiles. The companies will try to identify n...